De novo kidney transplantation with antibody induction
0.14 mg/kg/day
Month 1: 6-11 ng/mL >Month 1: 4-11 ng/mL
Conversion from tacrolimus immediate-release formulations
80% of the pre-conversion dose of tacrolimus immediate-release
Titrate to 4-11 ng/mL
drug label
Envarsus prescribing information
Have more Envarsus questions?
Submit MSL Request
Learn More
Your request will be referred to the appropriate Veloxis Pharmaceuticals, Inc medical professional, such as a Envarsus pharmaceutical rep; Medical Science Liaison (MSL) or medical affairs.
Need to report an Envarsus issue?
ONLINE FORMReport adverse event
Learn More
You can report a Envarsus adverse event on MedWatch, the FDA's medical product safety reporting program for health professionals, patients and consumers.
samples
Request Envarsus samples
NOT PROVIDED BY BRANDView Online Sample Form
Learn More
Is my patient elegible for Envarsus samples?
Your rep will communicate with you how to receive samples, when you can receive samples, the amount and more.
How do I find out who my Envarsus rep is?
Not sure who your local Envarsus pharma rep is? Reach out to Veloxis Pharmaceuticals, Inc and they can help you identify your rep.
prior authorization
Envarsus Prior authorization resources
NOT PROVIDED BY BRANDComplete Letter of Medical Necessity
NOT PROVIDED BY BRANDCoverage Authorization Request
NOT PROVIDED BY BRANDCoverage Authorization Appeals
Learn More
If available, these templates are provided by the brand to help you navigate insurance, especially with newer drugs.
Benefits investigation
Veloxis Transplant Support Form - Online
Veloxis Transplant Support Form
Veloxis Transplant Support Form - Spanish
Learn More
Benefits investigations are conducted to determine whether a therapy is covered under a patient's insurance, if a prior authorization is required, and which specialty pharmacies are preferred.
Reimbursement help (FRM)
Receive Assistance from an FRM Regarding Reimbursement Information
Learn More
Some brands offer a field reimbursement manager who will work with your clinical staff and preferred pharmacy to help make sure patients don't fall through the cracks.
financial assistance
Envarsus Financial assistance options
Co-pay savings program
commercial only
Enroll in Patient Savings Program
Learn More
Overview
Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)
Patient benefit
A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max
Patient eligibility
Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance
How to sign up
Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form
Bridge program
commercial only
Veloxis Transplant Support Form - Online
Veloxis Transplant Support Form
Veloxis Transplant Support Form - Spanish
Learn More
Overview
Provide patient immediate access to therapy during an insurance delay (typically new starts; some may cover change in insurance)
Limited time/ fill (typically 7-30 days; some may offer additional fill for continued delay up to certain limit)
Patient benefit
100% free (outside of insurance)
Patient eligibility
HCP must enroll patient
May be limited to commercially insured patients (i.e., no government beneficiaries); some programs may allow government beneficiaries
How to sign up
Typically HCP assisted enrollment (via form)
Foundation programs
under insured
no insurance
goverment insurance
65+
Veloxis Transplant Support Form - Online
Veloxis Transplant Support Form
Veloxis Transplant Support Form - Spanish
Patient Assistance Program
Learn More
Overview
Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned
Patient benefit
Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted
Patient eligibility
Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.
How to sign up
Patients submit proof of out-of-pocket drug costs to charities for reimbursement
patient education
Envarsus Patient education
Getting started on Envarsus
NOT PROVIDED BY BRANDInstructions For Use: Rejection Prophylaxis in Kidney Transplant
Patient toolkit
About Envarsus XR
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
View How to Take Envarsus XR
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
Patient Resources
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
Learn More
Other resources brands publish to help support patients and caregivers.
Can't find what you're looking for?
Our trained staff can help you:
Please note:
Access to a Field Reimbursement Manager (FRM) or Medical Science Liaison (MSL) varies by brand and may require talking with your rep first.
Samples are provided at the discretion of the brand.
We are unable to collect Protected Health Information (PHI), fill out forms, or submit them on your behalf.
